Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription 22.06.2026 1 Am J Hematol 4 Blood 1 BMC Neurol 1 Br J Cancer 6 Br J Haematol 3 Haematologica 1 J Natl Cancer Inst 1 Leuk Lymphoma 1 Leukemia 1 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. SMITH SD, Sundaram S, Giri S, Ness A, et al
   Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.
   Am J Hematol. 2026 Jun 17. doi: 10.1002/ajh.70406.
   PubMed         Abstract available
   
   

   
   Blood

2. FALCONER J
   The RELEVANCE of long-term follow-up in follicular lymphoma.
   Blood. 2026;147:2993-2994.
   PubMed        
   
   
3. SPECHT L
   Less is more in primary cutaneous indolent B-cell lymphoma.
   Blood. 2026;147:2992-2993.
   PubMed        
   
   
4. 
   Diefenbach CS, Jegede O, Wang V, et al. A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026;147(18):2041-2052.
   Blood. 2026;147:3123.
   PubMed        
   
   
5. KIM WS, Kim SJ, Yoon DH, Cho H, et al
   Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).
   Blood. 2026 Jun 12:blood.2025032636. doi: 10.1182/blood.2025032636.
   PubMed         Abstract available
   
   

   
   BMC Neurol

6. UTHAYASURIYAN N, Gowthaman SR, Pachiyappan JS, Damodaran AC, et al
   Third ventricle non-Hodgkin lymphoma: An unusual presentation of primary central nervous system lymphoma.
   BMC Neurol. 2026 Jun 18. doi: 10.1186/s12883-026-05087.
   PubMed         Abstract available
   
   

   
   Br J Cancer

7. ZHOU H, Liu Q, Ren K, Luo Q, et al
   KPT-330-mediated XPO1 inhibition impairs homologous recombination and enhances radiosensitivity in extranodal NK/T-cell lymphoma.
   Br J Cancer. 2026 Jun 16. doi: 10.1038/s41416-026-03492.
   PubMed         Abstract available
   
   

   
   Br J Haematol

8. SABATTINI E, Ascani S, Ciavarella S, Di Napoli A, et al
   Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in Italy.
   Br J Haematol. 2026;208:2016-2025.
   PubMed         Abstract available
   
   
9. EYRE TA
   Where next for BTKi-BCL2i combinations in mantle cell lymphoma?
   Br J Haematol. 2026 Jun 14. doi: 10.1111/bjh.70621.
   PubMed         Abstract available
   
   
10. ZHANG M, Chen Y
    Response alone does not define optimal bridging before brexucabtagene autoleucel in mantle cell lymphoma.
    Br J Haematol. 2026 Jun 14. doi: 10.1111/bjh.70615.
    PubMed        
    
    
11. CASERTA S, Martino EA, Vigna E, Bruzzese A, et al
    Minimal residual disease in diffuse large B-cell lymphoma after first-line therapy: Defining the continuum from metabolic remission to molecular clearance.
    Br J Haematol. 2026 Jun 14. doi: 10.1111/bjh.70619.
    PubMed         Abstract available
    
    
12. ITONAGA H, Fukushima T, Kato K, Muranushi H, et al
    Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experience.
    Br J Haematol. 2026 Jun 15. doi: 10.1111/bjh.70631.
    PubMed         Abstract available
    
    
13. CERIANI L, Milan L, Cascione L, Di Rocco A, et al
    Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.
    Br J Haematol. 2026 Jun 16. doi: 10.1111/bjh.70614.
    PubMed         Abstract available
    
    

    
    Haematologica

14. GIORDANO C, Picardi M
    Early Intensification with bendamustine supercharge plus brentuximab vedotinfollowing failure to obtain complete metabolic remission after two cycles of ABVD inpatients aged
    Haematologica. 2026 Jun 18. doi: 10.3324/haematol.2026.301273.
    PubMed         Abstract available
    
    
15. DONG S, Wang M, Luo Z, Wu W, et al
    Glofitamab plus polatuzumab vedotin: a novel safe, and highly effective chemotherapy-free regimen for pediatric relapsed/refractory B-cell non-Hodgkin lymphoma.
    Haematologica. 2026 Jun 18. doi: 10.3324/haematol.2026.300836.
    PubMed         Abstract available
    
    
16. LEE JY, Kim SA, Yang DH, Eum HS, et al
    Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphoma.
    Haematologica. 2026 Jun 18. doi: 10.3324/haematol.2026.300790.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

17. ROGERS JR, Ward ZJ, Stratton KL, Leisenring WM, et al
    Modeling long-term mortality and morbidity in pediatric Hodgkin lymphoma survivors after reduced radiotherapy exposure.
    J Natl Cancer Inst. 2026 Jun 12:djag186. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

18. GONG IY, Xiao NM, Chen C, Bhella S, et al
    Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.
    Leuk Lymphoma. 2026 Jun 15:1-5. doi: 10.1080/10428194.2026.2682290.
    PubMed        
    
    

    
    Leukemia

19. RENDERS S, Ngoya M, de Leval L, Finel H, et al
    Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.
    Leukemia. 2026 Jun 15. doi: 10.1038/s41375-026-02993.
    PubMed        
    
    

    
    N Engl J Med

20. CLIFF ERS, Kenealy M
    Immunosuppression-Associated Peripheral T-Cell Lymphoma.
    N Engl J Med. 2026;394:2356.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum